COLUCCI, ROCCHINA LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.758
AS - Asia 4.479
EU - Europa 3.213
SA - Sud America 1.397
AF - Africa 1.343
OC - Oceania 148
Continente sconosciuto - Info sul continente non disponibili 70
Totale 22.408
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.069
SG - Singapore 1.483
IT - Italia 873
BR - Brasile 854
HK - Hong Kong 728
CN - Cina 532
VN - Vietnam 410
FI - Finlandia 265
PL - Polonia 201
DE - Germania 159
GB - Regno Unito 145
FR - Francia 140
RU - Federazione Russa 124
CL - Cile 94
NL - Olanda 93
AR - Argentina 91
IE - Irlanda 81
SE - Svezia 81
TR - Turchia 81
EC - Ecuador 72
IN - India 66
ID - Indonesia 62
AT - Austria 60
MX - Messico 57
JP - Giappone 56
PY - Paraguay 54
PH - Filippine 53
CI - Costa d'Avorio 51
IQ - Iraq 49
VE - Venezuela 49
ZA - Sudafrica 49
ES - Italia 47
KE - Kenya 46
MK - Macedonia 46
PA - Panama 46
SA - Arabia Saudita 46
TW - Taiwan 46
ME - Montenegro 45
RO - Romania 45
UZ - Uzbekistan 45
HR - Croazia 44
PS - Palestinian Territory 44
TT - Trinidad e Tobago 44
UA - Ucraina 44
CH - Svizzera 42
KG - Kirghizistan 42
PE - Perù 42
IS - Islanda 41
EE - Estonia 40
HT - Haiti 40
MA - Marocco 40
ML - Mali 40
TN - Tunisia 40
UG - Uganda 40
UY - Uruguay 40
AE - Emirati Arabi Uniti 39
CO - Colombia 39
CW - ???statistics.table.value.countryCode.CW??? 39
EG - Egitto 39
BE - Belgio 38
BW - Botswana 38
BY - Bielorussia 38
RE - Reunion 38
CR - Costa Rica 37
DZ - Algeria 37
KR - Corea 37
AO - Angola 36
BG - Bulgaria 36
CZ - Repubblica Ceca 36
IR - Iran 36
JM - Giamaica 36
KH - Cambogia 36
MZ - Mozambico 36
PT - Portogallo 36
RS - Serbia 36
RW - Ruanda 36
SK - Slovacchia (Repubblica Slovacca) 36
YT - Mayotte 36
BB - Barbados 35
CD - Congo 35
GN - Guinea 35
HN - Honduras 35
IL - Israele 35
LC - Santa Lucia 35
MY - Malesia 35
NO - Norvegia 35
NP - Nepal 35
PK - Pakistan 35
SI - Slovenia 35
SN - Senegal 35
CG - Congo 34
GE - Georgia 34
JO - Giordania 34
MD - Moldavia 34
NZ - Nuova Zelanda 34
BZ - Belize 33
GF - Guiana Francese 33
TH - Thailandia 33
TZ - Tanzania 33
ZW - Zimbabwe 33
Totale 20.823
Salva come PNG Salva come JPEG
Città #
Fairfield 1.976
Woodbridge 1.272
Ashburn 1.074
Houston 979
Ann Arbor 970
Seattle 709
Hong Kong 702
Singapore 673
Cambridge 657
Wilmington 614
Chandler 286
Boardman 256
San Diego 203
Medford 189
Princeton 189
Des Moines 153
Bytom 152
Dong Ket 152
Padova 145
Beijing 139
Helsinki 104
Ho Chi Minh City 96
Los Angeles 82
Dublin 66
Nanjing 64
São Paulo 58
Milan 56
Roxbury 56
Chicago 55
Redondo Beach 54
Hanoi 53
Verona 52
Abidjan 47
Santa Clara 47
Buffalo 44
Santiago 43
Tashkent 41
New York 40
Panama City 40
Vienna 40
Kampala 38
Podgorica 38
Nairobi 37
Nuremberg 37
Kigali 36
Munich 36
Bamako 35
Bishkek 35
Dakar 35
Phnom Penh 35
Castries 34
Conakry 34
Willemstad 34
Amman 33
London 33
Shenyang 33
Tallinn 33
Bridgetown 32
Baku 31
Noumea 31
Harare 30
Ulan Bator 30
Kingstown 29
Libreville 29
Montevideo 29
Havana 28
Hebei 28
Maputo 28
Cotonou 27
Dushanbe 27
Luanda 27
Rome 27
Vientiane 27
Dar es Salaam 26
Lusaka 26
Niamey 26
Nouakchott 26
Reykjavik 26
Cayenne 25
Gaborone 25
Kinshasa 25
Lima 25
Managua 25
Minsk 25
Nassau 25
Quito 25
Riga 25
San José 25
Yerevan 25
Zagreb 25
Antananarivo 24
Brazzaville 24
Istanbul 24
Kingston 24
Ljubljana 24
Praia 24
Skopje 24
Tbilisi 24
Belo Horizonte 23
Djibouti 23
Totale 14.352
Salva come PNG Salva come JPEG
Nome #
Goodman & Gilman. Le basi farmacologiche della terapia. Con espansione online 536
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 311
Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders 225
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 195
Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis 193
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 182
398 Rifaximin Displays a Protective Activity in Experimental Enteropathy Induced by Indomethacin in Rats 176
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 169
1077 AMP-Activated Protein Kinase as a Novel Target for the Pharmacological Treatment of Inflammatory Bowel Diseases 168
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 166
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 163
Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: A preclinical study 161
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 161
Effects of maternal obesity and direct exposure to high-fat diet on bowel functions in offsprings 160
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 159
Impact of Antibiotic-Induced Microbiota Depletion on Small Bowel Excitatory and Inhibitory Neuromuscular Pathways in Adolescent Mice 158
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 158
Tu1889 Targeting of NLRP3 Inflammasome With a Novel Selective Inhibitor as a Suitable Strategy for the Pharmacological Treatment of Bowel Inflammation 157
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 157
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 156
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 156
L-histidine decarboxylase decreases its own transcription through downregulation of ERK activity 153
Anti-inflammatory effect of a novel locally acting A2Areceptor agonist in a rat model of oxazolone-induced colitis 153
Immunohistochemical Analysis of Myenteric Ganglia and Interstitial Cells of Cajal in Ulcerative Colitis 152
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage 151
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 151
Exploring the genetics of irritable bowel syndrome: A GWA study in the general population and replication in multinational case-control cohorts 151
Colonic Dysmotility Associated with High Fat Diet-Induced Obesity: Role of the Enteric Glia 151
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists 151
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 150
The ecto-enzymes CD73 and adenosine deaminase modulate 5′-AMP-derived adenosine in myofibroblasts of the rat small intestine 150
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 150
Effects of L-DOPA/Benserazide Co-Treatment on the Patterns of Colonic Neuromuscular Excitatory Cholinergic and Tachykininergic Pathways in the Presence of Experimental Parkinson's Disease 149
Histamine H3 receptors mediate inhibition of noradrenaline release from intestinal sympathetic nerves 148
Role of peripheral GABAB receptors in the regulation of pepsinogen secretion in anaesthetized rats 148
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis 148
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 147
A 2,3-diphenylpyrido[1,2-a] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-alpha 146
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 146
Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan. 145
Altered expression pattern of molecular factors involved in colonic smooth muscle functions: an immunohistochemical study in patients with diverticular disease 144
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 144
Microvascular Endothelial Dysfunction in Patients with Obesity 143
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration 143
CCK-1 and CCK-2 receptors regulate gastric pepsinogen secretion 142
Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice 141
Mo2044 Irritable Bowel Syndrome, Serotonin Transporter 5HTTLPR Polymorphism and Psychopathological Traits: Dangerous Relations? 141
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 140
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 140
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 140
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 139
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 138
Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats. 137
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 137
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 136
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 136
Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy 136
PACAP and gastrin regulate the histidine decarboxylase promoter via distinct mechanisms 135
Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds 135
Adenosine pathway and cancer: Where do we go from here? 135
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? 135
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 134
Adenosine and inflammation: what's new on the horizon? 134
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 134
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 133
Central administration of cholecystokinin stimulates gastric pepsinogen secretion from anaesthetized rats. 132
Mo1810 Cyclooxygenase Inhibitors Counteract PRO-Fibrotic Signalling in Experimental Colitis Through Modulation of TGF-Beta/SMAD Network 132
A holistic view of adenosine pathways in the control of intestinal neuromuscular functions: the enteric purinome concept 131
H3 receptor-mediated inhibition of intestinal acetylcholine release: pharmacological characterization of signal transduction pathways 130
Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 129
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 129
SU2045 Characterization of Excitatory and Inhibitory Neuromuscolar Pathways Regulating Colonic Motility in a Rat Model of Parkinson's Disease 129
Role of cyclooxygenase pathways in bowel fibrotic remodeling in a murine model of experimental colitis 128
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 128
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis 127
Su2089 Fibrotic Remodelling and Damage of the Colonic Neuromuscular Compartment in the Presence of Bowel Inflammation 127
Colonic Dysmotility Associated With High Fat Diet-Induced Obesity: Involvement of Endogenous Adenosine via a2B Receptors 127
Central GABA-A receptors exert a tonic inhibitory control on gastric pepsinogen secretion in anaesthetized rats 125
Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence 125
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 124
Sa1694 Colonic Inflammation in Experimental Parkinson's Disease: Evidence of Altered Colonic Tachykininergic Neurotransmissio 124
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role 123
The β3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats 123
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 123
Influence of Toll- like receptor 4 signaling on high- fat diet induced dysmotility in mouse small intestine 123
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 122
Effects of L-DOPA/Benserazide Co-Treatment on Colonic Dysmotility and Enteric Inflammation Following Dopaminergic Nigrostriatal Neurodegeneration 120
Impact of diet-induced maternal obesity and effects of high-fat diet on bowel functions in offsprings 120
The effects of obesity superimposed with aging in female mouse model 120
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 119
Derivatives of benzimidazol-2-ylquinoline and benzimidazol-2-ylisoquinoline as selective A1 adenosine receptor antagonists with stimulant activity on human colon motility 118
W1720 Effects of Proton Pump Inhibitors on Healing of NSAID-Induced Gastric Ulcerations in the Presence of a Continued NSAID Treatment: Characterization of Molecular Mechanisms 118
Sa1702 Alterations of Colonic Neuromuscular Excitatory Tachykininergic Pathways in a Mouse Model of Diet Induced-Obesity 117
Microvascular endothelial dysfunction in human obesity: role of TNF-α 117
Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 down-regulation 117
Alterations of Colonic Neuromuscular Excitatory Cholinergic Pathway in a Rat Model of 6-Hydroxydopamine-Induced Parkinson's Disease 116
Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis 115
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis 115
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 115
Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications 114
Totale 14.661
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.024
article - articoli 64.356
book - libri 736
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.555
Totale 136.671
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.784 0 0 0 0 67 461 87 151 410 136 207 265
2021/20222.178 62 181 346 182 94 105 86 265 137 52 187 481
2022/20231.045 326 27 10 75 211 123 14 71 116 9 39 24
2023/2024760 33 62 63 64 68 48 47 47 25 75 105 123
2024/20253.512 12 98 114 134 381 68 148 241 455 205 790 866
2025/20267.395 372 1.545 2.365 2.595 518 0 0 0 0 0 0 0
Totale 22.778